vs
高乐氏（CLX）与Moolec Science SA（MLEC）财务数据对比。点击上方公司名可切换其他公司
高乐氏的季度营收约是Moolec Science SA的633.0倍（$1.7B vs $2.6M）。高乐氏净利率更高（9.4% vs -91.8%，领先101.2%）
高乐氏是美国跨国企业，专业从事消费级与专业用途产品的生产及营销。2000年至2024年持续入选《财富》500强榜单，最新排名为第485位，旗下产品覆盖清洁护理、家居日用等多个品类，在全球消费市场拥有较高认可度。
Moolec Science SA是一家专注于分子农业的农业生物技术与食品科技企业，通过改造作物平台生产可持续、高性价比的动物源蛋白，可应用于人造肉、乳制品及食品配料领域，服务全球多地的食品生产商与消费品品牌。
CLX vs MLEC — 直观对比
营收规模更大
CLX
是对方的633.0倍
$2.6M
净利率更高
CLX
高出101.2%
-91.8%
损益表 — Q2 2026 vs Q2 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $2.6M |
| 净利润 | $157.0M | $-2.4M |
| 毛利率 | 43.2% | -25.5% |
| 营业利润率 | — | -77.9% |
| 净利率 | 9.4% | -91.8% |
| 营收同比 | 0.3% | — |
| 净利润同比 | -15.6% | — |
| 每股收益（稀释后） | $1.29 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLXMLEC
| Q4 25 | $1.7B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | $2.6M | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.8B | — | ||
| Q4 23 | $2.0B | — |
净利润CLXMLEC
| Q4 25 | $157.0M | — | ||
| Q2 25 | $332.0M | — | ||
| Q1 25 | $186.0M | — | ||
| Q4 24 | $193.0M | $-2.4M | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $216.0M | — | ||
| Q1 24 | $-51.0M | — | ||
| Q4 23 | $93.0M | — |
毛利率CLXMLEC
| Q4 25 | 43.2% | — | ||
| Q2 25 | 46.5% | — | ||
| Q1 25 | 44.6% | — | ||
| Q4 24 | 43.8% | -25.5% | ||
| Q3 24 | 45.8% | — | ||
| Q2 24 | 46.5% | — | ||
| Q1 24 | 42.2% | — | ||
| Q4 23 | 43.5% | — |
营业利润率CLXMLEC
| Q4 25 | — | — | ||
| Q2 25 | 20.6% | — | ||
| Q1 25 | 15.2% | — | ||
| Q4 24 | 14.1% | -77.9% | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 14.5% | — | ||
| Q1 24 | -2.3% | — | ||
| Q4 23 | 6.8% | — |
净利率CLXMLEC
| Q4 25 | 9.4% | — | ||
| Q2 25 | 16.7% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 11.4% | -91.8% | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 11.4% | — | ||
| Q1 24 | -2.8% | — | ||
| Q4 23 | 4.7% | — |
每股收益（稀释后）CLXMLEC
| Q4 25 | $1.29 | — | ||
| Q2 25 | $2.68 | — | ||
| Q1 25 | $1.50 | — | ||
| Q4 24 | $1.54 | $-0.06 | ||
| Q3 24 | $0.80 | — | ||
| Q2 24 | $1.74 | — | ||
| Q1 24 | $-0.41 | — | ||
| Q4 23 | $0.75 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $227.0M | $1.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-125.0M | $2.8M |
| 总资产 | $5.6B | $31.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLXMLEC
| Q4 25 | $227.0M | — | ||
| Q2 25 | $167.0M | — | ||
| Q1 25 | $226.0M | — | ||
| Q4 24 | $290.0M | $1.9M | ||
| Q3 24 | $278.0M | — | ||
| Q2 24 | $202.0M | — | ||
| Q1 24 | $219.0M | — | ||
| Q4 23 | $355.0M | — |
总债务CLXMLEC
| Q4 25 | — | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
股东权益CLXMLEC
| Q4 25 | $-125.0M | — | ||
| Q2 25 | $321.0M | — | ||
| Q1 25 | $27.0M | — | ||
| Q4 24 | $-41.0M | $2.8M | ||
| Q3 24 | $60.0M | — | ||
| Q2 24 | $328.0M | — | ||
| Q1 24 | $91.0M | — | ||
| Q4 23 | $53.0M | — |
总资产CLXMLEC
| Q4 25 | $5.6B | — | ||
| Q2 25 | $5.6B | — | ||
| Q1 25 | $5.5B | — | ||
| Q4 24 | $5.6B | $31.4M | ||
| Q3 24 | $5.5B | — | ||
| Q2 24 | $5.8B | — | ||
| Q1 24 | $5.8B | — | ||
| Q4 23 | $5.9B | — |
负债/权益比CLXMLEC
| Q4 25 | — | — | ||
| Q2 25 | 7.74× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 7.56× | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLX
| Health And Wellness | $643.0M | 38% |
| Household | $419.0M | 25% |
| Lifestyle | $321.0M | 19% |
| Other | $290.0M | 17% |
MLEC
暂无分部数据
